Robust Meta-Model for Predicting the Need for Blood Transfusion in Non-traumatic ICU Patients

TL;DR

This study develops a machine learning meta-model to accurately predict blood transfusion needs within 24 hours for a diverse group of non-traumatic ICU patients, enhancing resource allocation and patient care.

Contribution

It introduces a novel meta-learning approach that outperforms individual models in predicting transfusion requirements across a broad ICU patient population.

Findings

Meta-model achieves AUROC of 0.97

Model accuracy of 0.93 and F1-score of 0.89

Effective in diverse non-traumatic ICU patients

Abstract

Objective: Blood transfusions, crucial in managing anemia and coagulopathy in ICU settings, require accurate prediction for effective resource allocation and patient risk assessment. However, existing clinical decision support systems have primarily targeted a particular patient demographic with unique medical conditions and focused on a single type of blood transfusion. This study aims to develop an advanced machine learning-based model to predict the probability of transfusion necessity over the next 24 hours for a diverse range of non-traumatic ICU patients. Methods: We conducted a retrospective cohort study on 72,072 adult non-traumatic ICU patients admitted to a high-volume US metropolitan academic hospital between 2016 and 2020. We developed a meta-learner and various machine learning models to serve as predictors, training them annually with four-year data and evaluating on the fifth, unseen year, iteratively over five years. Results: The experimental results revealed that the meta-model surpasses the other models in different development scenarios. It achieved notable performance metrics, including an Area Under the Receiver Operating Characteristic (AUROC) curve of 0.97, an accuracy rate of 0.93, and an F1-score of 0.89 in the best scenario. Conclusion: This study pioneers the use of machine learning models for predicting blood transfusion needs in a diverse cohort of critically ill patients. The findings of this evaluation confirm that our model not only predicts transfusion requirements effectively but also identifies key biomarkers for making transfusion decisions.